Index RUT
P/E -
EPS (ttm) -0.49
Insider Own 24.37%
Shs Outstand 43.67M
Perf Week 5.29%
Market Cap 662.39M
Forward P/E -
EPS next Y -0.34
Insider Trans 2.41%
Shs Float 33.11M
Perf Month -2.32%
Income -21.43M
PEG -
EPS next Q -0.14
Inst Own 53.84%
Short Float 6.75%
Perf Quarter 61.30%
Sales 84.82M
P/S 7.81
EPS this Y 5.44%
Inst Trans -3.47%
Short Ratio 5.76
Perf Half Y 182.54%
Book/sh 2.31
P/B 6.54
EPS next Y 26.68%
ROA -15.91%
Short Interest 2.24M
Perf Year 161.31%
Cash/sh 1.80
P/C 8.42
EPS next 5Y -
ROE -20.39%
52W Range 4.60 - 20.90
Perf YTD 121.85%
Dividend Est. -
P/FCF -
EPS past 5Y 20.06%
ROI -21.11%
52W High -27.61%
Beta 0.78
Dividend TTM -
Quick Ratio 5.27
Sales past 5Y 37.03%
Gross Margin 86.54%
52W Low 228.91%
ATR (14) 0.94
Dividend Ex-Date -
Current Ratio 5.52
EPS Y/Y TTM 77.54%
Oper. Margin -30.27%
RSI (14) 50.77
Volatility 5.23% 6.11%
Employees 100
Debt/Eq 0.01
Sales Y/Y TTM 29.96%
Profit Margin -25.26%
Recom 1.86
Target Price 21.43
Option/Short Yes / Yes
LT Debt/Eq 0.01
EPS Q/Q -187.26%
Payout -
Rel Volume 1.20
Prev Close 15.00
Sales Surprise 11.53%
EPS Surprise 89.80%
Sales Q/Q -25.71%
Earnings Feb 29 AMC
Avg Volume 387.91K
Price 15.13
SMA20 -0.20%
SMA50 -2.99%
SMA200 72.66%
Trades
Volume 467,186
Change 0.87%
Date
Action
Analyst
Rating Change
Price Target Change
May-10-23 Upgrade
Wedbush
Neutral → Outperform
$5 → $13
Apr-03-23 Downgrade
Guggenheim
Buy → Neutral
Jan-27-23 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$4
Jan-05-23 Downgrade
Cowen
Outperform → Market Perform
Dec-02-22 Downgrade
BofA Securities
Buy → Neutral
$23 → $5
Dec-02-22 Downgrade
BofA Securities
Buy → Neutral
Oct-31-22 Downgrade
Wedbush
Outperform → Neutral
$6
Oct-31-22 Downgrade
JP Morgan
Neutral → Underweight
$16 → $7
Jul-06-22 Resumed
Canaccord Genuity
Buy
$35
Jun-24-22 Initiated
BMO Capital Markets
Outperform
$27
Feb-03-22 Resumed
Guggenheim
Buy
$22
Nov-19-21 Resumed
Morgan Stanley
Equal-Weight
$25
Nov-16-21 Downgrade
JP Morgan
Overweight → Neutral
$57 → $30
May-07-21 Upgrade
BofA Securities
Neutral → Buy
Apr-23-21 Resumed
Cowen
Outperform
Mar-22-21 Resumed
JP Morgan
Overweight
$57 → $52
Jan-15-21 Downgrade
BofA Securities
Buy → Neutral
$56
Nov-09-20 Reiterated
H.C. Wainwright
Buy
$52 → $65
May-05-20 Initiated
Barclays
Overweight
$44
May-01-20 Initiated
Janney
Buy
Show Previous Ratings
Mar-28-24 09:55AM
Mar-20-24 07:37AM
Mar-14-24 09:05AM
Mar-12-24 09:55AM
Mar-05-24 12:00PM
08:45AM
Loading…
Mar-04-24 08:45AM
07:30AM
Mar-01-24 09:42PM
(Thomson Reuters StreetEvents) +11.92%
Feb-29-24 05:25PM
04:37PM
04:05PM
Feb-22-24 10:00AM
Feb-16-24 07:30AM
Feb-13-24 04:10AM
Jan-02-24 04:05PM
04:05PM
Loading…
Dec-13-23 04:05PM
Dec-12-23 01:05AM
Dec-03-23 03:04AM
Nov-30-23 11:04PM
Nov-15-23 01:14PM
01:33AM
(Thomson Reuters StreetEvents)
Nov-13-23 05:31PM
05:25PM
04:05PM
Nov-08-23 12:00PM
Oct-31-23 07:05AM
Oct-18-23 04:05PM
Oct-17-23 04:05PM
Oct-16-23 04:05PM
Sep-21-23 04:05PM
04:05PM
Loading…
Sep-06-23 04:05PM
Aug-23-23 09:55AM
Aug-13-23 06:25AM
Aug-10-23 05:15PM
04:05PM
Aug-02-23 04:05PM
Aug-01-23 04:05PM
Jul-26-23 12:35PM
Jun-02-23 03:15PM
May-26-23 09:00AM
09:00AM
May-23-23 09:00AM
May-18-23 06:39AM
May-13-23 08:18AM
May-10-23 06:14AM
02:52AM
(Thomson Reuters StreetEvents)
May-08-23 05:15PM
04:01PM
May-01-23 10:01AM
Apr-28-23 09:00AM
Apr-18-23 09:00AM
Apr-17-23 10:57AM
Apr-05-23 07:44PM
09:55AM
09:00AM
Apr-04-23 05:12AM
Mar-30-23 05:25PM
04:01PM
02:42PM
Mar-21-23 04:01PM
Mar-15-23 10:22AM
Feb-20-23 10:00AM
Feb-16-23 10:01AM
07:57AM
Feb-02-23 09:00AM
Jan-05-23 10:34AM
Jan-04-23 04:01PM
Jan-03-23 09:00AM
Dec-21-22 09:00AM
Dec-16-22 04:01PM
Dec-14-22 09:00AM
Dec-08-22 09:00AM
Dec-07-22 09:19AM
Dec-06-22 09:00AM
Dec-01-22 05:34PM
Nov-07-22 05:15PM
04:01PM
Nov-02-22 04:01PM
Oct-31-22 03:01PM
08:52AM
05:34AM
Oct-28-22 03:33PM
Oct-06-22 09:34AM
Oct-03-22 09:00AM
Sep-29-22 02:53AM
Sep-26-22 09:00AM
Sep-09-22 08:35AM
Sep-01-22 04:05PM
Aug-30-22 09:00AM
Aug-13-22 08:29AM
Aug-08-22 05:45PM
04:05PM
Aug-02-22 09:00AM
Jul-12-22 09:00AM
Jun-30-22 07:31AM
May-31-22 09:00AM
May-26-22 04:01PM
May-09-22 05:25PM
04:01PM
May-03-22 04:01PM
Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Gad Thomas CHIEF BUSINESS OFFICER Mar 05 '24 Sale 16.44 3,900 64,116 158,700 Mar 07 05:01 PM Rajah Vignesh SVP & CHIEF MEDICAL OFFICER Mar 05 '24 Sale 16.53 1,711 28,283 33,889 Mar 07 05:02 PM Smith Susan Laura SVP & CHIEF COMMERCIAL OFFICER Mar 05 '24 Sale 16.55 1,682 27,837 33,918 Mar 07 04:59 PM Gad Thomas Chief Business Officer Dec 21 '23 Option Exercise 2.00 50,000 100,000 140,500 Dec 26 04:15 PM Gad Thomas Chief Business Officer Dec 15 '23 Sale 6.61 50,000 330,500 265,032 Dec 15 07:40 PM Gad Thomas Chief Business Officer Dec 14 '23 Sale 6.83 50,000 341,500 315,032 Dec 15 07:40 PM Gad Thomas Chief Business Officer Dec 13 '23 Sale 6.58 50,000 329,000 365,032 Dec 15 07:40 PM Wedell-Wedellsborg Johan Director Dec 11 '23 Buy 7.01 102,863 720,843 4,552,778 Dec 11 05:25 PM WG Biotech ApS Director Dec 11 '23 Buy 7.01 102,863 720,843 4,552,778 Dec 11 05:25 PM Wedell-Wedellsborg Johan Director Dec 11 '23 Buy 6.85 6,455 44,232 4,559,233 Dec 12 08:26 AM WG Biotech ApS Director Dec 11 '23 Buy 6.85 6,455 44,232 4,559,233 Dec 12 08:27 AM WG Biotech ApS Director Dec 08 '23 Buy 6.99 18,503 129,379 4,449,915 Dec 11 05:25 PM Wedell-Wedellsborg Johan Director Dec 08 '23 Buy 6.99 18,503 129,379 4,449,915 Dec 11 05:25 PM Wedell-Wedellsborg Johan Director Dec 07 '23 Buy 6.50 6,183 40,190 4,431,412 Dec 11 05:25 PM WG Biotech ApS Director Dec 07 '23 Buy 6.50 6,183 40,190 4,431,412 Dec 11 05:25 PM Wedell-Wedellsborg Johan Director Nov 29 '23 Buy 5.97 51,837 309,477 4,425,229 Dec 01 05:14 PM WG Biotech ApS Director Nov 29 '23 Buy 5.97 51,837 309,477 4,425,229 Dec 01 05:15 PM Wedell-Wedellsborg Johan Director Nov 28 '23 Buy 5.81 30,671 178,275 4,373,392 Nov 29 05:15 PM WG Biotech ApS Director Nov 28 '23 Buy 5.81 30,671 178,275 4,373,392 Nov 29 05:14 PM WG Biotech ApS Director Nov 27 '23 Buy 5.49 62,516 343,019 4,342,721 Nov 29 05:14 PM Wedell-Wedellsborg Johan Director Nov 27 '23 Buy 5.49 62,516 343,019 4,342,721 Nov 29 05:15 PM Gad Thomas Chief Business Officer Nov 21 '23 Sale 5.31 75,000 397,988 415,032 Nov 22 05:00 PM Gad Thomas Chief Business Officer Nov 20 '23 Sale 5.30 75,000 397,395 490,032 Nov 22 05:00 PM Wedell-Wedellsborg Johan Director May 15 '23 Buy 9.65 101,740 981,404 4,280,205 May 17 05:07 PM WG Biotech ApS Director May 15 '23 Buy 9.65 101,740 981,404 4,280,205 May 17 05:05 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite